A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120 W61D derived from dual tropic R5X4 HIV-1 ACH320

Author： McCormack S.   Tilzey A.   Carmichael A.   Gotch F.   Kepple J.   Newberry A.   Jones G.   Lister S.   Beddows S.   Cheingsong R.   Rees A.   Babiker A.   Banatvala J.   Bruck C.   Darbyshire J.   Tyrrell D.   Van Hoecke C.   Weber J.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.13, 2000-01, pp. : 1166-1177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

By Nitayaphan S.   Khamboonruang C.   Sirisophana N.   Morgan P.   Chiu J.   Duliege A.-M.   Chuenchitra C.   Supapongse T.   Rungruengthanakit K.   deSouza M.   Mascola J.R.   Boggio K.   Ratto-Kim S.   Markowitz L.E.   Birx D.   Suriyanon V.   McNeil J.G.   Brown A.E.   Michael R.A.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1448-1455

Elsevier

Access to resources Recommend Favorite

A Phase I safety and immunogenicity trial of UBI(R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

By Lambert J.S.   Keefer M.   Mulligan M.J.   Schwartz D.   Mestecky J.   Weinhold K.   Smith C.   Hsieh R.   Moldoveanu Z.   Fast P.   Forrest B.   Koff W.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3033-3042

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120

By Fouts T.R.   Tuskan R.G.   Chada S.   Hone D.M.   Lewis G.K.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1697-1705

Elsevier

Access to resources Recommend Favorite

Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

By Liang X.   Munshi S.   Shendure J.   Mark G.   Davies M.E.   Freed D.C.   Montefiori D.C.   Shiver J.W.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2862-2872

Elsevier

Access to resources Recommend Favorite